Substitution therapy for alcoholism: time for a reappraisal? (Q48248695)

9 February 2018

title

Substitution therapy for alcoholism: time for a reappraisal? (English)

1 reference

9 February 2018

0 references

David J Nutt

2

0 references

author name string

Jonathan Chick

series ordinal

1

1 reference

9 February 2018

language of work or name

English

0 references

publication date

8 July 2011

1 reference

9 February 2018

Journal of Psychopharmacology

published in

1 reference

9 February 2018

volume

26

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

205-212

1 reference

9 February 2018

Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Rapid suppression of alcohol withdrawal syndrome by baclofen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Maintaining abstinence from alcohol with gamma-hydroxybutyric acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Suppression of alcohol delirium tremens by baclofen administration: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

(-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Suppression of symptoms of alcohol dependence and craving using high-dose baclofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Gamma-hydroxybutyrate (GHB) for the treatment of alcohol dependence: a call for further understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Gamma-hydroxybutyrate receptor function studied by the modulation of nitric oxide synthase activity in rat frontal cortex punches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Critical review of liability for benzodiazepine abuse among alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Abstinence symptoms after withdrawal of tranquillising drugs: is there a common neurochemical mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Severe gamma-hydroxybutyrate withdrawal: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Diazepam Maintenance of Alcohol Preference During Alcohol Withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Acute interaction of baclofen in combination with alcohol in heavy social drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Baclofen for alcohol dependence: a preliminary open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Gamma hydroxy butyrate abuse and dependency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

The effect of diazepam on voluntary ethanol intake in a rat model of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Lorazepam substitutes for the alcohol stimulus in social drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Benzodiazepine treatment for alcohol-dependent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Baclofen and gamma-hydroxybutyrate withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

A retrospective chart review comparing tiagabine and benzodiazepines for the treatment of alcohol withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Alcohol and the brain. Pharmacological insights for psychiatrists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Low-dose diazepam primes motivation for alcohol and alcohol-related semantic networks in problem drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Does gamma-hydroxybutyrate (GHB) have a role in the treatment of alcoholism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Gamma-hydroxybutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Behavioral disinhibition with baclofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

GABAB receptors in addiction and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Gamma-hydroxybutyric acid: neurobiology and toxicology of a recreational drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Diazepam dose-dependently increases or decreases implicit priming of alcohol associations in problem drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

Clinical use of benzodiazepines and decreased memory activation in anxious problem drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881111408463

21 January 2018

Identifiers

DOI

10.1177/0269881111408463

1 reference

9 February 2018

1 reference

9 February 2018